VisionHealth’s Kata® Clinical app to support sterna biologicals’ clinical Phase Ila asthma trial Kata® Clinical app supports Phase Ila proof-of-concept study investigating sterna biologicals’ lead compound SB010 in moderate to severe asthma patients Kata® Clinical will be used to enhance inhaler device handling and therapy adherence, reduce drop-out rates and

VisionHealth adds Clinical Trial Function to Kata® App supporting and optimizing inhalation therapy of chronic lung diseases Kata® Clinical, the new specialized version of Kata® offers clinical trial specific extended functionality Kata® Clinical can be customized to partners’ needs; options include data management and result validation, patient management, inhalation training and monitoring, recording

Inhalation 2.0 – Knowing what enters the lungs The German Aerosol Therapy Symposium (DATS) will enter its 22nd round on November 6-7, 2020, but this time not in a familiar way. The DATS team has decided to offer the symposium as a hybrid event for the first time due to